SUV remains the most widely used PET parameter to evaluate NHLs because it is directly associated with lymphoma aggressiveness.

Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) Chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) are very similar because they have the same type of ...

Lymphocyte differentiation is a process in which activated B cells or T cells become specialized immune cells. For example, B cells can give rise to antibody-producing cells and T cells can ...

Lymphoid cells develop into other types of white blood cells: lymphocytes and natural killer cells. If you have leukemia, a developing stem cell in your bone marrow begins to multiply out of control.

Small lymphocytic lymphoma (SLL) is a slow-growing cancer of the immune system. It is typically manageable with treatment, but outlook can depend on a few factors. SLL is one type of non-Hodgkin ...

Table 1 Human chemokines and chemokine receptors in lymphocyte traffic: a functional classification into inflammatory (pale green) and homeostatic (dark green) chemokines. Chemokines belonging to ...

Patients with CLL may benefit from the incorporation of more plant-based foods into their diet. 2,4 This could include adopting a flexitarian approach, in which the diet primarily consists of ...

Surgery is not often used as a treatment option for chronic lymphocytic leukemia (CLL) because the disease is usually widely spread in the bone marrow and other organs. However, surgery may sometimes ...

Lymphocyte-activation gene 3 (LAG-3) has emerged as a key immune checkpoint regulating immune responses in the context of cancer. The inhibitory effect of LAG-3-expressing T cells contributes to ...

Patient-derived xenograft (PDX) models of chronic lymphocytic leukemia (CLL) can help analyze the biology of primary leukemic B and T cells in an in vivo setting (1–7). However, creating successful ...